RPS and Marie Curie develop ‘professional standards in palliative care’ for community pharmacy


Share post:

The Royal Pharmaceutical Society (RPS) and the charity Marie Curie have developed a consultation on ‘professional standards for palliative and end of life care for community pharmacy’.

The consultation will be open for four weeks for community pharmacists, organisations with a role in community pharmacy or palliative/end of life care, or patients or carers with first-hand experience of palliative and end of life care to share their views until 1st December 2022.

Through this consultation, Society aims to that ensure the standards are clear, relevant, current, and fit for purpose from the perspective of the community pharmacy team, the wider health team and patients/carers.

“The final standards will be published in 2023 and will help community pharmacies across the UK to self-assess and continuously improve their palliative, end of life and bereavement care,” said RPS.

“The standards have been informed by thorough review of existing best practice across the UK and internationally, as well as a professional steering group consisting of community pharmacy experts, experts within the field of palliative care, lay members and healthcare professionals interacting community pharmacy.”

The standards cover eight core areas which community pharmacies should strive to deliver. Some examples of these are:

  • Early identification and recording that a person has an Advanced Serious Illness or end of lifecare needs
  • Care is based on the assessed unique needs of the patient, carer and family
  • Care after death, and bereavement support

Darrell Baker, Chair of the Daffodil Standards steering group, said: “It is vital for us to get as many views as possible through the consultation so that community pharmacy teams can work together to deliver the best quality of care to palliative and end of life patients and their carers.

“The standards have been informed by thorough review of existing best practice across the UK and internationally. They have also been developed in collaboration with an expert multi-professional steering group and with support from the RPS Community Pharmacy Expert Advisory Group.”

The work aligns with and compliments the established RCGP and Marie Curie ‘Daffodil Standards for advanced serious illness and end of life care” for GP practices.


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...